NHS trialled pioneering new CAR T-cell therapy on student Harry Brown and is now rolling it out to other leukaemia patients

A new leukaemia “cure” which reprogrammes immune cells to tackle the cancer is being offered on the NHS .

The country’s top cancer doctor has announced rollout of the new form of CAR (chimeric antigen receptor) T-cell therapy which sees T cells removed and modified in a laboratory so they can recognise cancer cells. It is used to tackle acute lymphoblastic leukaemia which is an aggressive cancer in the blood and bone marrow.

Professor Peter Johnson, NHS National Clinical Director for Cancer, said: “This ‘living medicine’ boosts a patient’s own immune system and then guides T-cells towards the cancer to kill it.

READ MORE : Child leukaemia cure hope after youn

See Full Page